HomeOpenAI launches GPT-Rosalind model or biology, drug discovery research
The model, which integrates with 50+ scientific tools under controlled access, aims to help researchers explore more possibilities and identify connections that may otherwise be missed, potentially improving the quality of early-stage research decisions.
The model, which integrates with 50+ scientific tools under controlled access, aims to help researchers explore more possibilities and identify connections that may otherwise be missed, potentially improving the quality of early-stage research decisions.
Disclaimer: This content has been automatically aggregated from Enterprise AI for informational purposes. To read the original article, please visit Enterprise AI.
